Hodgkin's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Hodgkin's Disease, including details on causes, cancer, lymphoma, stages, symptoms.

Volume 4 (2007), Issue 1 (January)

1. Tandem high-dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: a monocenter prospective study.
   Am J Hematol, 82(2): 122-7. [Abstract] [Full-text]
2. Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease.
   J Clin Oncol, 25(3): 332-7. [Abstract] [Full-text]
3. Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome.
   Blood, 109(3): 905-9. [Abstract] [Full-text]
4. Risk of second malignant neoplasms among lymphoma patients with a family history of cancer.
   Int J Cancer, 120(5): 1099-102. [Abstract] [Full-text]

© 2004-2012 Hodgkin's Disease Research Today. All Rights Reserved.